Clinical Research
Filter News
Found 105,719 articles
-
Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.
-
The mice had been genetically modified to have symptoms similar to Alzheimer’s. They were given a synthetic version of tetrahydrocannabinol (THC) for six weeks. In their study, the mice receiving the THC performed as well on a memory test as the healthy mice.
-
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardio...
11/13/2018
Viagra (sildenafil), Pfizer’s blockbuster drug for erectile dysfunction, is a classic example of how a drug developed for one thing can turn out to be successful for another. -
Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.
-
Kymera Therapeutics secured $65 million in a Series B funding round that was supported, in part, by the investment arms of Pfizer and Sanofi.
-
New ABET Report Offers Recommendations for Higher Education to Scale Global Learning Opportunities for Students
11/13/2018
Diverse and global learning experiences for higher education STEM students are critical to solving the world’s greatest sustainability challenges, according to a new report by ABET, released this week at the WEEF-GEDC Peace Engineering Conference.
-
BOC Sciences Recently Updates Its Metabolites and Impurities Collection
11/13/2018
Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research community.
-
American Diabetes Association® Issues Position Statement on Comprehensive Care of Pediatric Patients with Type 2 Diabetes
11/13/2018
The incidence of type 2 diabetes (T2D) in people under the age of 20 is increasing in the United States, with one national study indicating a 4.8 percent increase of newly diagnosed cases of T2D in the age group from 2002 to 2012.
-
Cerus Endovascular Enrolls First Patients in CERUS Study to Treat Intra-Cranial Aneurysms Using Contour Neurovascular System™ to Reduce the Risk of Rupture
11/13/2018
Cerus Endovascular Ltd., a privately held medical device company engaged in developing interventional neuroradiology devices and delivery systems to treat acute, life-threatening intracranial aneurysms, today announced enrollment of the first patients in the CERUS Study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study).
-
Preterm Birth Diagnostic Test Kits Market to Grow US$ 200 Mn By 2028 | Top Players- Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products and Others
11/13/2018
A new study by the company titled 'Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018–2028', has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market.
-
Clinical Study Of OPTIFAST® Meal Replacement Program Demonstrates Significant Sustained Weight Loss In Patients With Obesity
11/13/2018
In the year-long OPTIWIN randomized, head-to-head, clinical trial, the OPTIFAST Program resulted in an average weight loss two-fold higher than a reduced-calorie, food-based diet and lifestyle intervention.
-
Leading Burn Surgeons Present Positive RECELL® System Results at 31st Annual Southern Region Burn CME Conference and Northeast Region Burn Conference
11/13/2018
Burn surgeon presents health economic model projecting burn center will save up to USD $21 million per year treating patients with the RECELL System compared to conventional treatment
-
McGill, Yale and Universities of Pennsylvania and Massachusetts Join PanFAM-1, the Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer
11/13/2018
New centers give study near complete coverage of North American FPC sites in drive to validate IMMrayTM PanCan-d, the first blood based test for early detection of pancreatic cancer
-
NYU Winthrop's Advances in Detecting and Treating Preterm Infant Feeding Problems Are Expected to Prompt Paradigm Shift in Protocol Across U.S., Improving Neonatal Outcomes and Reducing Medical Expenses
11/13/2018
Hospital's Research Also Shows That Cold Milk Can "Startle" Infant's Swallowing Movements to Work Better in Preterm Infants with Feeding Problems
-
The Global Cannabis Market Continues to Grow as Medical Cannabis Legalization Spreads
11/13/2018
According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.
-
Northwestern Mutual Study Reveals Most Caregivers Are Overwhelmed Emotionally And Lack Adequate Emotional Support
11/13/2018
Caregiving is a growing reality for Americans – one that comes with a significant emotional toll, according to findings from Northwestern Mutual's 2018 C.A.R.E Study.
-
Juniper Research: Vehicle-Based Payments to Propel Financial IoT to $410 Billion in Transactions by 2023
11/13/2018
Fuel & Toll Payments the First Big Wins for the Financial IoT
-
Global Genomics Group (G3) Presents Data for the First Time on the Exact Size of Lipoprotein (a) Particles that Cause Plaque Buildup in Coronary Arteries from its GLOBAL Clinical Study Platform
11/13/2018
Data presented at the Annual Scientific Sessions of the American Heart Association in Chicago, IL on November 12, 2018.
-
Food Safety Can Be Crucial For People With Diabetes
11/13/2018
November is National Diabetes Month.
-
Becker's Hospital Review And Validic Release Results From Executive Survey On Remote Monitoring Adoption, Barriers
11/13/2018
Nearly 53 percent of provider organizations are piloting and deploying remote monitoring and virtual care programs